Previous Chapter: References
Suggested Citation: "Appendix A: Meeting Agendas." Institute of Medicine. 2014. Review of NASA's Evidence Reports on Human Health Risks: 2013 Letter Report. Washington, DC: The National Academies Press. doi: 10.17226/18575.

A

Meeting Agendas

First Meeting of the
Committee to Review NASA’s Evidence Reports
on Human Health Risks

Telephone Conference

Wednesday, August 7, 2013

OPEN SESSION

11:30 a.m.

Official Charge to the Committee

Mark Shelhamer, Chief Scientist, Human Research Program, NASA

 

 

11:50 a.m.

Discussion of Statement of Task with the Committee

Facilitator: Carol Scott-Conner, Committee Chair

 

 

12:45 p.m.

Public Session Adjourn

Suggested Citation: "Appendix A: Meeting Agendas." Institute of Medicine. 2014. Review of NASA's Evidence Reports on Human Health Risks: 2013 Letter Report. Washington, DC: The National Academies Press. doi: 10.17226/18575.

Second Meeting of the
Committee to Review NASA’s Evidence Reports
on Human Health Risks

National Academy of Sciences Building
2101 Constitution Avenue, NW
Lecture Room
Washington, DC

Monday, September 30, 2013

OPEN SESSION

9:00 a.m.

Welcome

Carol Scott-Conner, Committee Chair

 

 

9:15 a.m.

Panel 1: Risk of Injury from Dynamic Loads

Facilitator: Larry Young, Committee Member

   Jim Brinkley, Air Force Research Laboratory, Retired

   John R. Buhrman, Air Force Research Laboratory

   Roger Nightingale, Duke University

10:45 a.m.

Break

11:00 a.m.

Panel 2: Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Facilitator: Prem Subramanian, Committee Member

   Tom Mader, Alaska Native Medical Center

   Michael Williams, Sinai Hospital of Baltimore

   Neil Miller, Johns Hopkins University

 

 

12:30 p.m.

Lunch

 

 

Suggested Citation: "Appendix A: Meeting Agendas." Institute of Medicine. 2014. Review of NASA's Evidence Reports on Human Health Risks: 2013 Letter Report. Washington, DC: The National Academies Press. doi: 10.17226/18575.

1:15 p.m.

Panel 3: Risk of Clinically Relevant Unpredicted Effects of Medication

Facilitator: Eleanor O’Rangers, Committee Member

   Tina Bayuse, Wyle Science, Technology and Engineering Group

   Tom Marshburn, NASA

   Peter Bauer, NASA

   David Nicolau, Hartford Hospital

2:45 p.m.

Public Testimony—Registered Speakers

Moderator: Carol Scott-Conner, Committee Chair

 

 

3:15 p.m.

Public Session Adjourn

Suggested Citation: "Appendix A: Meeting Agendas." Institute of Medicine. 2014. Review of NASA's Evidence Reports on Human Health Risks: 2013 Letter Report. Washington, DC: The National Academies Press. doi: 10.17226/18575.

This page intentionally left blank.

Suggested Citation: "Appendix A: Meeting Agendas." Institute of Medicine. 2014. Review of NASA's Evidence Reports on Human Health Risks: 2013 Letter Report. Washington, DC: The National Academies Press. doi: 10.17226/18575.
Page 41
Suggested Citation: "Appendix A: Meeting Agendas." Institute of Medicine. 2014. Review of NASA's Evidence Reports on Human Health Risks: 2013 Letter Report. Washington, DC: The National Academies Press. doi: 10.17226/18575.
Page 42
Suggested Citation: "Appendix A: Meeting Agendas." Institute of Medicine. 2014. Review of NASA's Evidence Reports on Human Health Risks: 2013 Letter Report. Washington, DC: The National Academies Press. doi: 10.17226/18575.
Page 43
Suggested Citation: "Appendix A: Meeting Agendas." Institute of Medicine. 2014. Review of NASA's Evidence Reports on Human Health Risks: 2013 Letter Report. Washington, DC: The National Academies Press. doi: 10.17226/18575.
Page 44
Next Chapter: Appendix B: Committee Biosketches
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.